Molecular Partners AG ADR Company Profile
NASDAQ: MOLNHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
3.81+0.03 (+0.79%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Molecular Partners at a glance
Molecular Partners AG ADR (NASDAQ: MOLN) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector. The company's shares have traded publicly since 2021. At a market capitalization of $141.8 million, it is considered a small-cap company.
Its SEC Central Index Key (CIK) is 0001745114, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
Company information
- Legal name
- Molecular Partners AG ADR
- Ticker
- NASDAQ: MOLN
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- Headquarters
- Switzerland
- IPO year
- 2021
- Market cap
- $141.79M
- SEC CIK
- 0001745114
Companies similar to Molecular Partners
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| AVXLAnavex Life Sciences Corp. | 1.53 | -4.38% | $141.83M | vs MOLN |
| ARMPArmata Pharmaceuticals Inc. | 3.81 | -1.04% | $141.66M | vs MOLN |
| OTLKOutlook Therapeutics Inc. | 0.59 | +3.15% | $143.63M | vs MOLN |
| ABOSAcumen Pharmaceuticals Inc. | 2.10 | +3.45% | $151.87M | vs MOLN |
| VYGRVoyager Therapeutics Inc. | 2.47 | +0.41% | $152.20M | vs MOLN |
| HUMAHumacyte Inc. | 0.4723 | -1.19% | $131.20M | vs MOLN |
| TARAProtara Therapeutics Inc. | 2.59 | +1.37% | $153.06M | vs MOLN |
| CHRSCoherus Oncology Inc. | 1.01 | -1.94% | $156.05M | vs MOLN |